![Michael Teifel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Teifel
Chief Tech/Sci/R&D Officer at
CEAPRO INC.
Net worth: - $ as of 2026-05-30
Profile
Michael Teifel was the founder of Munich Biotech AG, founded in 1998, where the title held was Head-Pharmacology & Toxicology from 1998 to 2004.
Current jobs include Chief Scientific Officer & Senior Vice President at COSCIENS Biopharma, Inc. since 2021, and Chief Scientific Officer & SVP-Clinical at Ceapro, Inc. Former jobs include Vice President-Non Clinical Services at Aeterna Zentaris GmbH from 2014 to 2019, Vice President-Non Clinical Sciences at Æterna Zentaris, Inc. from 2014 to 2021, and Head-Translational Sciences at Cleara Biotech BV.
Education includes a doctorate from Technische Universität Darmstadt conferred in 1996.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
-.--% | 2025-12-30 | 0 ( -.--% ) | - $ | 2026-05-30 |
Michael Teifel active positions
| Companies | Position | Start |
|---|---|---|
| CEAPRO INC. | Chief Tech/Sci/R&D Officer | - |
Former positions of Michael Teifel
| Companies | Position | End |
|---|---|---|
AEterna Zentaris GmbH
 AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services Engages in biopharmaceutical research specializing in oncology and endocrinology | Corporate Officer/Principal | 2019-09-30 |
Munich Biotech AG
 Munich Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Founder | 2004-07-31 |
Cleara Biotech BV
 Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Corporate Officer/Principal | - |
Æterna Zentaris, Inc.
 Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Chief Tech/Sci/R&D Officer | - |
Training of Michael Teifel
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
26
1st degree connections
6
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
Æterna Zentaris, Inc.
Æterna Zentaris, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceutical products for diagnosis of adult growth hormone deficiency | Health Technology |
Ceapro, Inc.
 Ceapro, Inc. BiotechnologyHealth Technology Develops and commercializes active ingredients and anti-aging products for for healthcare and cosmetic industries | Health Technology |
Munich Biotech AG
Munich Biotech AG Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Technische Universität Darmstadt
 Technische Universität Darmstadt Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AEterna Zentaris GmbH
AEterna Zentaris GmbH Miscellaneous Commercial ServicesCommercial Services Engages in biopharmaceutical research specializing in oncology and endocrinology | Commercial Services |
Cleara Biotech BV
Cleara Biotech BV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
- Stock Market
- Insiders
- Michael Teifel
